Haystack iS (iatricSystems)

Deliberate B rather than the A given to Protenus, and the distinction is instructive. The AI is real and named: Solomon is a purpose-built detection engine evaluating multiple signals and learning organisation-specific baselines by role, department, shift and workflow. But iatricSystems is a 35-year healthcare integration company whose moat is the integration estate, more than 180 vendor connections built across 200-plus customers and thousands of data feeds, and Haystack has existed for over two decades as Security Audit Manager with AI added over time rather than being the founding premise. The company itself frames AI as one capability within a privacy programme rather than the product. Same reasoning applied to Asimily and Censinet: where the durable asset is the integration network or dataset, AI Centrality is graded down even when the models are genuine.

A genuinely interesting split that a buyer should think through. On detection the posture is conservative and well stated: flagged behaviour means the activity was different enough to deserve a second look, not that access was inappropriate, and human judgment stays at the centre. Privacy teams can also adjust event weights themselves, which keeps the risk model under customer control rather than vendor control, a meaningful autonomy concession. But AVA takes an autonomous action with real consequences: on detecting potentially inappropriate access it CONTACTS THE USER DIRECTLY with a questionnaire before a human auditor has necessarily reviewed the case. That is efficient and it is also an automated system initiating what an employee will reasonably read as an accusation. Graded B because the detection philosophy is sound but no published threshold governs when AVA fires versus when a case routes to a human first.

Better than the category norm. The AI components are named and functionally distinguished, Solomon for detection and AVA for investigation automation, which is more specific than the undifferentiated AI most vendors describe, and the company explains the detection principle plainly: machine learning establishes what normal looks like within each organisation, accounting for role, department, shift and workflow differences, then flags deviation from that individual baseline. Explaining that a one-size-fits-all model is inappropriate for this problem is a substantive technical statement. Graded B rather than A because no accuracy, precision or false positive figures with methodology were located, and the strong claim to eliminate false positives appears in third party marketing without support.

Deep adoption and named references, no measured outcomes. Reported trust across 1,300 or more hospitals with 35 years of company history, and specific named customers with substantive detail: Renown Health consolidating thousands of daily PHI accesses into an actionable event list, and WVU Medicine running 23 hospitals in a 14-year partnership, whose privacy manager describes replacing separate audit reports across multiple clinical systems, EHRs, document management and lab applications with a single audit. A 14-year relationship at that scale is meaningful evidence of durability. Graded B rather than A because no independent benchmark, KLAS ranking or published detection performance data was located, unlike Protenus which holds Best in KLAS in this category.

The strongest published position on this axis in the entire cybersecurity category, and it earns the grade by addressing the question rather than asserting compliance. The company published guidance stating that organisations must understand how AI tools handle PHI, where data flows, whether information is retained or shared, and whether a Business Associate Agreement is in place, and explicitly raises vendor risk, staff training and shadow AI as considerations. It further argues that the best use of AI in privacy monitoring is focused and controlled, should reduce false positives and automate repetitive follow-up, and should keep human judgment central. A vendor that publishes the diligence questions customers should ask of AI vendors, including itself, is operating at a higher standard than one that simply claims HIPAA compliance. The platform necessarily aggregates PHI access data plus HR records, so the exposure is real, but the disclosure posture is the best available here.

HIPAA compliance support is the product's core purpose, with risk assessments, audit language and reporting fields alignable to organisational policy and HIPAA requirements, and reporting structured to improve OCR audit readiness. The company also names the Business Associate Agreement explicitly as something buyers must verify with AI vendors. Graded B rather than A because its own BAA terms were not located in published form.

No third party attestation such as SOC 2 Type II or HITRUST was retrieved at the time of review. Consistent with every vendor in this category, none of which publishes one.

Not an FDA regulated product. Privacy monitoring and compliance auditing sit outside Software as a Medical Device. The governing regulatory surface is the HIPAA Privacy and Security Rules, breach notification obligations, and Office for Civil Rights audit readiness, which the product is explicitly built around.

The best governance posture among the three workforce-surveillance vendors in this index, graded above Protenus and Bluesight, both at C. Three reasons. First, the company states plainly that a flag does not mean access was inappropriate, only that behaviour differed enough to warrant a second look, which is the correct epistemic framing for anomaly detection applied to people. Second, it explicitly rejects one-size-fits-all monitoring, noting that normal varies by role, department, shift and workflow, which directly addresses the failure mode where a clinician is flagged for legitimate practice that differs from a crude peer group. Third, customers can adjust event weights themselves, so the organisation rather than the vendor decides what counts as risky. Graded B rather than A because no subgroup performance analysis, appeal mechanism or false accusation rate is published, and because AVA's automated outreach to a flagged employee is a consequential action with no published governing threshold.

The deepest integration estate of any vendor in this category and arguably in this part of the index. Named EHR coverage spans Epic, Cerner, MEDITECH, Allscripts, athenahealth and Quadramed among more than 180 vendors, extending to document management including Hyland and Perceptive, clinical systems across PACS, pharmacy, lab and radiology, and HR platforms including Workday, PeopleSoft, ADP, Kronos and Active Directory. Backed by 35 years of integration experience across 200-plus customers and thousands of data feeds. Two things elevate this beyond a long list: an OPEN STANDARD AUDIT FILE IMPORT SPECIFICATION that works with virtually any system producing an audit file, and a stated commitment to build the integration if a customer's system is not already supported. Breadth matters more here than in most categories, because privacy monitoring only works if it sees every system where PHI is accessible, and the WVU Medicine account describes exactly the fragmentation this solves.

Designed to fit the customer's existing stack rather than requiring change, scaling from single facility to large multi-hospital enterprise systems, with v2 adding embedded how-to videos and a rebuilt interface to reduce onboarding friction. The open audit file import path means deployment is not gated on bespoke integration work for unusual systems. Graded B rather than A because no hosting architecture, deployment option or data residency terms were located.

No pricing published and no pricing basis disclosed. Third party comparison characterises the product as mid-to-enterprise priced with managed service options available, but that is external characterisation rather than vendor disclosure, and no rate or scaling basis is public.

Broad across systems and organisation sizes within a single risk domain. Scales from single facility to 23-hospital enterprises, covers PHI access wherever it occurs across clinical, document management, lab and administrative systems, and the parent company's wider portfolio spans drug diversion monitoring, EHR optimisation and interoperability. Graded B rather than A because this record covers patient privacy monitoring specifically per the product-scoping rule, and that is one risk domain, without the device security breadth of Asimily or Ordr or the dual privacy-plus-diversion coverage of Protenus.